Paper10690528
Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D and 8 others. Clin Cancer Res, 2000. Cited by 84 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. Papers, record 10690528. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10690528
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Colonic Neoplasms | Major topic |
| Colorectal Neoplasms | Major topic |
| Rectal Neoplasms | Major topic |
| Thymidylate Synthase | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Prognosis | |
| Survival Rate | |
| Time Factors | |
| Tumor Suppressor Protein p53 |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,457,133 | Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. | Cancer Drug Resist | 2023 | https://conductscience.org/library/papers/37457133 | PubMed |
| 33,652,782 | Rabdosianone I, a Bitter Diterpene from an Oriental Herb, Suppresses Thymidylate Synthase Expression by Directly Binding to ANT2 and PHB2. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33652782 | PubMed |
| 31,291,332 | High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma. | PLoS One | 2019 | https://conductscience.org/library/papers/31291332 | PubMed |
| 30,841,023 | Chemotherapy for Lung Cancer in the Era of Personalized Medicine. | Tuberc Respir Dis (Seoul) | 2019 | https://conductscience.org/library/papers/30841023 | PubMed |
| 30,200,215 | Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30200215 | PubMed |
| 27,325,685 | A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer. | Mol Cancer Ther | 2016 | https://conductscience.org/library/papers/27325685 | PubMed |
| 26,616,466 | TAS-102: a novel antimetabolite for the 21st century. | Future Oncol | 2016 | https://conductscience.org/library/papers/26616466 | PubMed |
| 25,702,261 | Role of KRAS mutation as predictor of pathologic response after neoadjuvant chemoradiation therapy for rectal cancer. | Updates Surg | 2015 | https://conductscience.org/library/papers/25702261 | PubMed |
| 25,114,572 | Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patients. | Onco Targets Ther | 2014 | https://conductscience.org/library/papers/25114572 | PubMed |
| 24,649,282 | Prognostic significance of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in biliary tract cancer patients receiving adjuvant 5-fluorouracil-based chemotherapy. | Mol Clin Oncol | 2013 | https://conductscience.org/library/papers/24649282 | PubMed |
| 24,453,997 | Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges. | Cancer Res Treat | 2013 | https://conductscience.org/library/papers/24453997 | PubMed |
| 23,438,367 | Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)-reactivating agents enhance efficacy of 5-fluorouracil on human colon cancer cells. | Cancer Sci | 2013 | https://conductscience.org/library/papers/23438367 | PubMed |
| 21,043,562 | Thymidylate synthase 1 (TS1) in-situ protein expression predicts the survival of Ewing/PNET. | Fetal Pediatr Pathol | 2010 | https://conductscience.org/library/papers/21043562 | PubMed |
| 20,072,795 | Clinical significance of dihydropyrimidine dehydrogenase and thymidylate synthase expression in patients with pancreatic cancer. | Int J Clin Oncol | 2010 | https://conductscience.org/library/papers/20072795 | PubMed |
| 19,537,845 | Clinical biomarkers in oncology: focus on colorectal cancer. | Mol Diagn Ther | 2009 | https://conductscience.org/library/papers/19537845 | PubMed |
| 19,444,465 | Nuclear thymidylate synthase expression in sporadic colorectal cancer depends on the site of the tumor. | Virchows Arch | 2009 | https://conductscience.org/library/papers/19444465 | PubMed |
| 18,597,678 | Clinical implications of thymidylate synthetase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activity levels in colorectal carcinoma following radical resection and administration of adjuvant 5-FU chemotherapy. | BMC Cancer | 2008 | https://conductscience.org/library/papers/18597678 | PubMed |
| 18,442,042 | Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer. | Cancer | 2008 | https://conductscience.org/library/papers/18442042 | PubMed |
| 17,934,851 | Prognostic and predictive value of thymidylate synthase expression in colon cancer. | Dig Dis Sci | 2008 | https://conductscience.org/library/papers/17934851 | PubMed |
| 16,753,067 | Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance. | BMC Cancer | 2006 | https://conductscience.org/library/papers/16753067 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TP53 | 7,157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| TYMS | 7,298 | PubTator's text mining | https://conductscience.org/library/genes/7298 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10690528
GET https://conductscience.org/api/papers/v1/10690528/cited_by?page=2